Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 6153215, 8 pages
http://dx.doi.org/10.1155/2016/6153215
Research Article

MAPK Pathways Are Involved in Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion

Department of Physical Medicine & Rehabilitation, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China

Received 21 December 2015; Accepted 28 June 2016

Academic Editor: Haroon Khan

Copyright © 2016 Yu-Juan Qu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Hargreaves, R. Dubner, F. Brown, C. Flores, and J. Joris, “A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia,” Pain, vol. 32, no. 1, pp. 77–88, 1988. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Tegeder, E. Niederberger, R. Schmidt et al., “Specific inhibition of IκB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats,” The Journal of Neuroscience, vol. 24, no. 7, pp. 1637–1645, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Gangadhar, R. K. Mishra, D. Sriram, and P. Yogeeswari, “Future directions in the treatment of neuropathic pain: a review on various therapeutic targets,” CNS and Neurological Disorders—Drug Targets, vol. 13, no. 1, pp. 63–81, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. F. V. Hassani, R. Rezaee, H. Sazegara, M. Hashemzaei, K. Shirani, and G. Karimi, “Effects of silymarin on neuropathic pain and formalin-induced nociception in mice,” Iranian Journal of Basic Medical Sciences, vol. 18, no. 7, pp. 715–720, 2015. View at Google Scholar · View at Scopus
  5. W. S. Kingery, “A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes,” Pain, vol. 73, no. 2, pp. 123–139, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. A. G. Turjanski, J. P. Vaqué, and J. S. Gutkind, “MAP kinases and the control of nuclear events,” Oncogene, vol. 26, no. 22, pp. 3240–3253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R.-R. Ji, H. Baba, G. J. Brenner, and C. J. Woolf, “Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity,” Nature Neuroscience, vol. 2, no. 12, pp. 1114–1119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. S.-X. Jin, Z.-Y. Zhuang, C. J. Woolf, and R.-R. Ji, “p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain,” The Journal of Neuroscience, vol. 23, no. 10, pp. 4017–4022, 2003. View at Google Scholar · View at Scopus
  9. Y. Kawasaki, T. Kohno, Z.-Y. Zhuang et al., “Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization,” The Journal of Neuroscience, vol. 24, no. 38, pp. 8310–8321, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Obata and K. Noguchi, “MAPK activation in nociceptive neurons and pain hypersensitivity,” Life Sciences, vol. 74, no. 21, pp. 2643–2653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. X.-S. Song, J.-L. Cao, Y.-B. Xu, J.-H. He, L.-C. Zhang, and Y.-M. Zeng, “Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats,” Acta Pharmacologica Sinica, vol. 26, no. 7, pp. 789–798, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R.-R. Ji, R. W. T. Gereau, M. Malcangio, and G. R. Strichartz, “MAP kinase and pain,” Brain Research Reviews, vol. 60, no. 1, pp. 135–148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Newton and V. M. Dixit, “Signaling in innate immunity and inflammation,” Cold Spring Harbor Perspectives in Biology, vol. 4, no. 3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Khan, O. Shehzad, H.-G. Jin et al., “Anti-inflammatory mechanism of 15,16-epoxy-3α-hydroxylabda-8,13(16),14-trien-7-one via inhibition of LPS-induced multicellular signaling pathways,” Journal of Natural Products, vol. 75, no. 1, pp. 67–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Koistinaho and J. Koistinaho, “Role of p38 and p44/42 mitogen-activated protein kinases in microglia,” Glia, vol. 40, no. 2, pp. 175–183, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. R.-R. Ji, K. Befort, G. J. Brenner, and C. J. Woolf, “ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity,” The Journal of Neuroscience, vol. 22, no. 2, pp. 478–485, 2002. View at Google Scholar · View at Scopus
  17. M.-G. Liu, R.-R. Wang, X.-F. Chen, F.-K. Zhang, X.-Y. Cui, and J. Chen, “Differential roles of ERK, JNK and p38 MAPK in pain-related spatial and temporal enhancement of synaptic responses in the hippocampal formation of rats: multi-electrode array recordings,” Brain Research, vol. 1382, pp. 57–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Choi, J. Y. Lee, E. J. Lim, H. H. Baik, T. H. Oh, and T. Y. Yune, “Inhibition of ROS-induced p38MAPK and ERK activation in microglia by acupuncture relieves neuropathic pain after spinal cord injury in rats,” Experimental Neurology, vol. 236, no. 2, pp. 268–282, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Black, L. Nikolajsen, K. Kroner, T. S. Jensen, and S. G. Waxman, “Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas,” Annals of Neurology, vol. 64, no. 6, pp. 644–653, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. L. D. Cesare Mannelli, C. Ghelardini, A. Toscano, A. Pacini, and A. Bartolini, “The neuropathy-protective agent acetyl-l-carnitine activates protein kinase C-γ and MAPKs in a rat model of neuropathic pain,” Neuroscience, vol. 165, no. 4, pp. 1345–1352, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. C. K. F. Lima, R. M. Silva, R. B. Lacerda et al., “LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain,” PLoS ONE, vol. 9, no. 6, Article ID e99510, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. D. J. Marcus, M. Zee, A. Hughes et al., “Tolerance to the antinociceptive effects of chronic morphine requires c-Jun N-terminal kinase,” Molecular Pain, vol. 11, no. 1, article 34, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. C. J. Young, P. Kihyun, and B. K. Young, “Inhibition of mitogen-activated protein kinases phosphorylation plays an important role in the anti-nociceptive effect of pregabalin in zymosan-induced inflammatory pain model,” Biological and Pharmaceutical Bulletin, vol. 37, no. 10, pp. 1694–1698, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. X.-L. Ding, Y.-H. Wang, L.-P. Ning et al., “Involvement of TRPV4-NO-cGMP-PKG pathways in the development of thermal hyperalgesia following chronic compression of the dorsal root ganglion in rats,” Behavioural Brain Research, vol. 208, no. 1, pp. 194–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Zhang, Y.-H. Wang, H.-Y. Ge, L. Arendt-Nielsen, R. Wang, and S.-W. Yue, “A transient receptor potential vanilloid 4 contributes to mechanical allodynia following chronic compression of dorsal root ganglion in rats,” Neuroscience Letters, vol. 432, no. 3, pp. 222–227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. X.-J. Song, D.-S. Xu, C. Vizcarra, and R. L. Rupert, “Onset and recovery of hyperalgesia and hyperexcitability of sensory neurons following intervertebral foramen volume reduction and restoration,” Journal of Manipulative and Physiological Therapeutics, vol. 26, no. 7, pp. 426–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Ma, K. W. Greenquist, and R. H. LaMotte, “Inflammatory mediators enhance the excitability of chronically compressed dorsal root ganglion neurons,” Journal of Neurophysiology, vol. 95, no. 4, pp. 2098–2107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Ono and J. Han, “The p38 signal transduction pathway: activation and function,” Cellular Signalling, vol. 12, no. 1, pp. 1–13, 2000. View at Publisher · View at Google Scholar
  29. S. Kumar, J. Boehm, and J. C. Lee, “p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases,” Nature Reviews Drug Discovery, vol. 2, no. 9, pp. 717–726, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. T.-J. Tseng, Y.-L. Hsieh, and S.-T. Hsieh, “Reversal of ERK activation in the dorsal horn after decompression in chronic constriction injury,” Experimental Neurology, vol. 206, no. 1, pp. 17–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. Z.-Y. Zhuang, Y.-R. Wen, D.-R. Zhang et al., “A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance,” The Journal of Neuroscience, vol. 26, no. 13, pp. 3551–3560, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. R. D. Rose, H. R. Koerber, M. J. Sedivec, and L. M. Mendell, “Somal action potential duration differs in identified primary afferents,” Neuroscience Letters, vol. 63, no. 3, pp. 259–264, 1986. View at Publisher · View at Google Scholar · View at Scopus